Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

7.1K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.1K
GPCR Desensitization01:12

GPCR Desensitization

7.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.8K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

2.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.6K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

10.6K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
10.6K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

5.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Construction and Evaluation of High-Efficiency Tannase-Producing Strains.

Microorganisms·2026
Same author

PEDV nucleocapsid (N) protein induces liquid-liquid phase separation (LLPS) to selectively aggregate the viral genome.

Veterinary microbiology·2026
Same author

Psychological characteristics of metacognitive strategy use and vocabulary development paths among vocational university students in a personalized english teaching environment.

BMC psychology·2026
Same author

A GLUT1-targeted peptide tracer for precision molecular imaging of esophageal squamous cell carcinoma: from early detection to intraoperative margin assessment.

Esophagus : official journal of the Japan Esophageal Society·2026
Same author

Efficacy and safety of disease-modifying oral drugs in treatment of relapsing-remitting multiple sclerosis: systematic review and network meta-analysis.

Frontiers in immunology·2026
Same author

ITPR3 promotes liver fibrosis by damaging hepatocytes via the Ca2+/NF-B/LECT2 pathway.

Scientific reports·2026

Related Experiment Video

Updated: Jan 4, 2026

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

13.5K

Arrestin-3 differentially regulates platelet GPCR subsets.

James L Hutchinson1, Xiaojuan Zhao1, Rob Hill1

  • 1School of Physiology, Pharmacology and Neuroscience, University of Bristol , Bristol, UK, BS8 1TD.

Platelets
|November 6, 2019
PubMed
Summary

Arrestin-3 limits G protein-coupled receptor signaling in platelets, acting as a brake on aggregation. This study reveals its complex, ligand-dependent roles in platelet activation and signaling pathways.

Keywords:
ArrestinGPCRP2Y1P2Y12PlateletsTP receptor

More Related Videos

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

1.3K
Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

7.3K

Related Experiment Videos

Last Updated: Jan 4, 2026

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

13.5K
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

1.3K
Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

7.3K

Area of Science:

  • Platelet biology
  • Molecular signaling
  • Pharmacology

Background:

  • Nonvisual arrestins, particularly arrestin-3, are known to limit G protein-coupled receptor (GPCR) signaling.
  • GPCRs play a critical role in platelet activation, but arrestin-3's function in this context is not well-defined.
  • Understanding arrestin-3's role is crucial for comprehending platelet response regulation.

Purpose of the Study:

  • To characterize the activatory responses of platelets lacking arrestin-3 (arr3-/-) in mice.
  • To elucidate the ligand-dependent functions of arrestin-3 in platelet signaling.
  • To determine arrestin-3's role in regulating platelet aggregation, secretion, and intracellular signaling.

Main Methods:

  • Basic characterization of platelet activatory responses in arr3-/- mice.
  • Assessment of platelet aggregation, secretion, and integrin activation.
  • Measurement of intracellular calcium signaling and PKC-dependent phosphorylation.
  • Evaluation of P2Y12 receptor activity via VASP phosphorylation.
  • Analysis of TP receptor signaling.

Main Results:

  • Arrestin-3 functions as a general brake on platelet aggregation across different GPCR ligands.
  • In arr3-/- platelets, enhanced secretion, integrin activation, calcium signaling, and PKC phosphorylation were observed downstream of P2Y and PAR receptors.
  • P2Y12 receptor activity was increased in arr3-/- mice.
  • TP receptor signaling showed reduced calcium responses but unaltered PKC activity, suggesting a positive regulatory role for arrestin-3 in TP signaling.

Conclusions:

  • Arrestin-3 exhibits pleiotropic, ligand-dependent roles in platelet activation.
  • This study demonstrates for the first time a negative regulatory function of arrestin-3 in platelet aggregation.
  • Arrestin-3's specific roles vary depending on the GPCR ligand, highlighting its complex involvement in platelet physiology.